{
    "case_number": "CAC-UDRP-109056",
    "time_of_filling": "2026-10-12 09:47:17",
    "domain_names": [
        "novartispharmagroup.com"
    ],
    "case_administrator": "Olga Slanařová (Case admin)",
    "complainant": [
        "Novartis AG"
    ],
    "complainant_representative": "Abion GmbH",
    "respondent": [
        "adam umaji"
    ],
    "respondent_representative": null,
    "factual_background": "<p><span>The Complainant is a Swiss company and the holding company of the Novartis Group, an international pharmaceutical group established in 1996. The Group develops and supplies medicines worldwide. Novartis Pharma Schweiz AG is a company within the Group.<\/span><\/p>\n<p><span>The Complainant operates an online presence through domain names incorporating its NOVARTIS trademark, including &lt;novartis.com&gt; and &lt;novartispharma.com&gt;.<\/span><\/p>\n<p><span>According to the Complaint, the disputed domain name was registered on April 10, 2026. The Registrar disclosed the underlying registrant as adam umaji, with an address in the Russian Federation. The publicly available registration information had identified a privacy service.<\/span><\/p>\n<p><span>The Complainant states that the disputed domain name has resolved to a German-language website promoting digital marketing services, including search engine optimisation, AI-assisted media placement and conversion services. The website presents those services under the name \"Novartis Pharma Schweiz AG\".&nbsp;<\/span><\/p>\n<p><span>The Complainant denies any affiliation with the Respondent and states that it has not authorised the Respondent to use its NOVARTIS trademark or the name of a Novartis Group company.<\/span><\/p>",
    "other_legal_proceedings": "<p>The Panel is not aware of any other legal proceedings which are pending or decided and which relate to the disputed domain name.<\/p>",
    "no_response_filed": "<p>The Complainant contends that the requirements of the Policy have been met and that the disputed domain name should be transferred to it. <br \/>No administratively compliant Response has been filed.<\/p>",
    "rights": "<p>The Complainant has, to the satisfaction of the Panel, shown the disputed domain name is identical or confusingly similar to a trademark or service mark in which the Complainant has rights (within the meaning of paragraph 4(a)(i) of the Policy).<\/p>",
    "no_rights_or_legitimate_interests": "<p>The Complainant has, to the satisfaction of the Panel, shown the Respondent to have no rights or legitimate interests in respect of the disputed domain name (within the meaning of paragraph 4(a)(ii) of the Policy).<\/p>",
    "bad_faith": "<p>The Complainant has, to the satisfaction of the Panel, shown the disputed domain name has been registered and is being used in bad faith (within the meaning of paragraph 4(a)(iii) of the Policy).<\/p>",
    "procedural_factors": "<p>The Panel is satisfied that all procedural requirements under UDRP were met and there is no other reason why it would be inappropriate to provide a decision.<\/p>",
    "decision": "Accepted",
    "panelists": [
        "Jan Schnedler"
    ],
    "date_of_panel_decision": "2026-11-05 00:00:00",
    "informal_english_translation": "<p><span>The Complainant relies on registered rights in the word mark NOVARTIS, including International Registration No. 663765, registered on July 1, 1996, and European Union Registration No. 013393641, registered on March 17, 2015.&nbsp;<\/span><\/p>",
    "decision_domains": {
        "novartispharmagroup.com": "TRANSFERRED"
    },
    "panelist": null,
    "panellists_text": null
}